Congratulations to Adicon Holdings Ltd. (9860.HK) on its Successful Listing on the Mainboard of HKSE on 30 June 2023
Adicon Holdings Ltd. (“Adicon”) is one of the three major independent medical laboratory (or ICL) service providers in China, mainly providing testing services to hospitals and medical examination centres through an integrated network of 33 self-operated laboratories throughout the country. According to Frost & Sullivan, as of December 31, 2022, Adicon has 18 laboratories accredited to ISO15189, ensuring quality assurance for customers that comply with this strict international standard. The company’s testing portfolio includes over 4000 medical diagnostic tests, including over 1700 general tests and over 2300 special tests.
Adicon’s comprehensive test offerings are supported by their advanced technologies focusing on a broad spectrum of testing platforms, as well as strong R&D capabilities. They operate a dedicated cold-chain logistics network covering more than 19,000 customers across 30 provinces and municipalities and over 1,600 cities and counties in China by the end of 2022, which ensures speedy transport of their samples and timely reporting of testing results. Meanwhile, Adicon leverages its proprietary IT infrastructure, Laboratory Information System, to ensure accurate processing and storage of data, as well as effective customer management across their laboratories nationwide. The company also assembled a dedicated sales and marketing team of over 1,500 personnel with high level of industry knowledge and expertise which empowered them to broaden their presence nationwide.
As a leading ICL service provider in China, Adicon is committed to providing high-quality testing services to patients and the general public, and has become a trustworthy and reliable partner for medical professionals and the general public.
With regard to this listing application, AVISTA Group is honored to be engaged in providing valuation services in relation to preferred shares, equity incentives, expected credit loss, purchase price allocation and goodwill impairment test.
Congratulations again to Adicon Holdings Ltd. (9860.HK) on its successful listing. The issue price is HKD 12.32 per share, and the amount of funds raised is HKD 409 million.
Meet Our People
VINCENT PANG
Managing Partner
AVISTA GROUP
vincent.pang@avaval.com
IVAN LUI
Partner
VALUATION ADVISORY
ivan.lui@avaval.com
HAILEY JIN
Partner
VALUATION ADVISORY
hailey.jin@avaval.com
JESSICA ZHONG
Partner
VALUATION ADVISORY
jessica.zhong@avaval.com
Date: 30 Jun 2023 | Tags: Initial Public Offering (IPO)
Latest News